September 13, 2018 PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI - Eligible PEA - SME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced its consolidated results for the six months ended June 30, 2018, as stated by the Board of Directors on September 12, 2018. First Half 2018 Financial
September 13, 2018 VANCOUVER, British Columbia--(BUSINESS WIRE)--According to a new series of reports by iData Research, the global spine market is valued at over $14.4 billion USD and is projected to approach $18 billion by 2023. Researched regions include the United States, 15 countries in Europe, 3 countries in Latin America, and 5 countries in
September 12, 2018 DUBLIN--(BUSINESS WIRE)--The "Global Orthopedic Trauma Fixation Devices Market - by Type of Internal Fixator, Composition, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The Global Orthopedic Trauma Fixation Devices Market was worth 7.52 Billion USD in 2017 and it is estimated to grow to
SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to which Stryker will acquire all of the outstanding shares of Invuity for $7.40 per
FARMINGDALE, N.Y., Sept. 06, 2018 (GLOBE NEWSWIRE) -- On September 5, 2018, Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), issued a press release announcing financial results of its fourth fiscal quarter and fiscal year ended June 30, 2018. The sales performance supplemental data table in that release included a classification error between international consumables and
FARMINGDALE, N.Y., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today reported financial results for the fiscal 2018 fourth quarter and year ended June 30, 2018 as summarized below: ($ in millions) Three Months Ended Year Ended June
SCHLIEREN (ZURICH), Switzerland, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX: KURN) has delivered on its targets in the first half of 2018, confirming its successful transition into a full-fledged orthobiologics company with scientific, clinical, and commercial excellence in bone regeneration. Kuros has recorded first sales of MagnetOs in the U.S. and in Europe, and
CARMEL, IND. (PRWEB) AUGUST 28, 2018 Nanovis, an innovative and fast-growing technology company selling nano-technology enhanced spinal implants, announced today the successful completion of a $5.5 million funding round managed by Commenda Securities. Key investors include Elevate Ventures, 1st Source Capital Corporation, Purdue’s Foundry Investment Fund, Commenda Capital, and Ellipsis Ventures. “Our investment in Nanovis is
AMSTERDAM, The Netherlands, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced the pricing of its previously announced registered underwritten public offering of 18,248,932 of its ordinary shares at an initial price to the public of $24.60 per share. The net proceeds to Wright from the offering, after deducting the underwriting
August 27, 2018 LYON, France & NEW YORK--(BUSINESS WIRE)--The Medicrea Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the transformation of spinal surgeries through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ technologies, announced today that the Company will begin trading on the OTCQX Best Market under the tickers “MRNTY” and
